latest news releases from the newsroom
MorphoSys Reports First Quarter 2005 Results
MARTINSRIED, Germany, April 28, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment, TecDAX) today reported financial results according to IFRS for its first quarter ended March 31, 2005. Revenues increased by 72% to 7.4 million, resulting in a quarterly net profit of 0.5 million, compared to a net loss in the previous year (March 31, 2004: 0.1 million loss). The Company's cash position equaled 51.1 million at the end of the first quarter 2005, up from 37.2 million at year-end 2004.
MorphoSys Provides Update on MOR102 Program in Psoriasis
MARTINSRIED, Germany, April 28, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (MOR; Prime Standard Segment, TecDAX) today provided an update on its MOR102 antibody program for chronic inflammatory diseases. As part of this program MorphoSys commissioned a pre-clinical study to compare the effectiveness of MOR102 with that of the approved biologics Amevive(R) and Raptiva(R) in an animal model of psoriasis. This study has now been completed and the results have been analyzed. Although therapeutic effects were observed for all tested compounds in several psoriatic skin samples, the in depth-analysis showed that it is not possible to discriminate on a statistically valid basis between compound-mediated effects and spontaneous healing observed in the negative control group. Hence, this study did not enable conclusions to be drawn regarding the efficacy of MOR102 versus Amevive(R) or Raptiva(R). The Company announced that it would continue to pursue the development and commercialization of MOR102 in chronic inflammation.
Nobel Biocare Group -- Interim Report 1, 2005
OPFIKON, Switzerland, April 28, 2005 (PRIMEZONE) -- Nobel Biocare (Other OTC:NBCHF) (Stockholm:NOBE) continues to outgrow the market and continues on high profitability level: revenue in local currencies up 25%, North America up 35%, EBIT margin now at 31.5%.
First Horizon National Corporation
First Horizon National Corp. to host Analyst/Investor Day May 3 in New York
MEMPHIS, Tenn., April 27, 2005 (PRIMEZONE) -- First Horizon National Corp. (NYSE:FHN) will hold an analyst/investor day May 3 at the Waldorf-Astoria at 301 Park Ave. in New York City. Numerous First Horizon executives will be on hand to answer questions from participants following presentations by Ken Glass, chairman and CEO; Jerry Baker, president of First Horizon Financial Services; Charles Burkett, president of First Tennessee Financial Services and Jim Hughes, president of FTN Financial. Registration will begin at 1 p.m. Eastern Time, and the presentations and panel discussion will take place between 1:30 p.m. and 5 p.m. A cocktail reception will follow from 5 p.m. -- 6 p.m.
Tribeworks, Inc. Announces Consolidation of Shares, Private Placement of Shares, New Director, and a New Corporate Direction
SAN FRANCISCO, April 27, 2005 (PRIMEZONE) -- Tribeworks (OTCBB:TRBW) is pleased to announce that as part of its previously announced plan of reorganization, the company intends to enter into the business of providing external Information Technology (IT) application support services for organizations with large IT functions. As its entry into this business, the company plans to acquire, for cash, TakeCareofIT Ltd., doing business as Atlas Technology Group, a Gibraltar Corporation that has recently been established to provide such services.
Brodsky & Smith, LLC
Law Offices of Brodsky & Smith, LLC Announces Class Action Lawsuit Against R & G Financial, Corp. -- RGF
BALA CYNWYD, Pa., April 27, 2005 (PRIMEZONE) -- Law offices of Brodsky & Smith, LLC today announces that a securities class action lawsuit has been filed on behalf of shareholders who purchased the common stock and other securities of R & G Financial, Corp. ("R & G" or the "Company") (NYSE:RGF), between April 21, 2003 and April 25, 2005, inclusive (the "Class Period").